Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Clinical Pharmacology and Therapeutics
>
2020
>
25
>
5
Volume:
25
Issue:
5
1. Characteristic and development of standard operating procedure of electronic data management in traditional Chinese medicine clinical research
Page:550—554
2. Design and practice of clinical trial management information system
Page:555—558
3. Effects of imipenem-cilastatin sodium combined with immunoglobulin on serum PCT, hs-CRP and TNF-α in children with baby sepsis complicated with disseminated intravascular coagulation
Page:559—565
4. Therapeutic drug monitoring and pharmacokinetics of new coronavirus pneumonia antiviral drugs
Page:566—575
5. Research progress in the mechanism of BRAF inhibitor resistance in melanoma
Page:576—583
6. Research Progress of Pirfenidone for connective tissue disease-associated interstitial lung diseases
Page:584—590
7. Clinical trials during post-COVID pandemic: An interim review
Page:591—594
8. Research progress on the mechanism and treatment of pelvic organ prolapse
Page:595—600
9. Protective effects of Xiaochaihu Decoction on chemical hepatic fibrosis in mice
Page:481—488
10. miR-138-5p protects β cell function by regulating HIF-1α in gestational diabetes mellitus
Page:489—497
11. Effects of pterostilbene on myocardial function, myocardial fibrosis and inflammatory response in rats with acute myocardial infarction and on Notch1/eIF3a signaling pathway
Page:498—504
12. AHVAC- inhibits the proliferation in human primary gastric cancer cells
Page:505—511
13. Yiqi Huoxue decoction inhibits malignant biological behavior of human lung cancer cells via the miR-21/PTEN signaling pathway
Page:512—518
14. Lidocaine inhibits the malignant proliferation, invasion and regulates the mitochondrial respiration of osteosarcoma MG-63 cells
Page:519—526
15. miR-106a regulates the proliferation of ovarian granulosa cells by targeting TIMP-2
Page:527—532
16. Lycium barbarum polysaccharide inhibits the proliferation and promots the apoptosis of osteosarcoma HOS cells by blocking Shh signaling pathway
Page:533—539
17. Missed and remedial dosage regimens of erlotinib by Monte Carlo simulation
Page:540—545
18. Discussion on the format and content of new drug population pharmacokinetic study report
Page:546—549